Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. MSFT
6. NVDA
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance

Gilead Sciences Announces Third Quarter 2018 Financial Results

October 25, 2018 4:01 PM EDT

- Product Sales of $5.5 billion -

- Diluted EPS of $1.60 per share -

- Non-GAAP Diluted EPS of $1.84 per share -

- Revised Full Year 2018 Guidance -

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the third quarter ended September 30, 2018. The financial results that follow represent a year-over-year comparison of the third quarter 2018 to the third quarter 2017. Total revenues were $5.6 billion in 2018 compared to $6.5... More